A Phase 3b, Multicenter, Open-label, PCI-32765 (Ibrutinib) Long-term Extension Study - Regional Cancer Care Associates LLC

Clinical Trials

A Phase 3b, Multicenter, Open-label, PCI-32765 (Ibrutinib) Long-term Extension Study

Type of Cancer
Lymphoma
Locations
Hackensack
Sponsor
Janssen
Protocol Number
PCI32765CAN3001-EXT
Cancer Diagnosis
To Learn More Call
201-510-0910